Company Overview and News

 
Mahanagar Telephone Nigam Limited - Shareholders meeting

2018-10-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500108 MTENY MTNL

 
MTNL may issue preferential shares to launch 4G services, looks to raise Rs 6,292 cr: Report

2018-10-11 moneycontrol
Mahanagar Telephone Nigam Ltd (MTNL) has sought the government's nod for issuance of preferential capital worth Rs 6,292 crore as it prepares to launch 4G services. The state-owned telecommunication service will soon release a tender to select a gear vendor partner for the rollout.
500108 MTENY MTNL

 
MTNL seeks Rs 6,000 cr equity from government to launch 4G services: Report

2018-10-11 moneycontrol
Mahanagar Telephone Nigam Ltd (MTNL) has sought the government's nod for issuance of preferential capital worth Rs 6,292 crore as it prepares to launch 4G services. The state-owned telecommunication service will soon release a tender to select a gear vendor partner for the rollout.
500108 MTENY MTNL

 
MTNL#39;s plans to hike borrowing limit, authorised capital, #39;enablers#39; for 4G roll-out : CMD

2018-09-03 moneycontrol
MTNL's plans to seek approval of shareholders for raising authorised share capital to Rs 10,000 crore and borrowing powers by almost 40 percent will aid the state-owned corporation's 4G plans and provide it the firepower to compete in the market, its chairman P K Purwar has said.
532454 500108 IDEA MTENY ICLQY 532822 MTNL BHRQY BHARTIARTL

3
MTNL ends with 10% gain on buzz of Rs 30,600 cr financial aid by DoT to cut debt

2018-08-30 moneycontrol
Shares of government-owned telecom operator MTNL (Mahanagar Telephone Nigam) ended 10 percent higher on Thursday based on a report that informed about Rs 30,600-crore financial aid from Department of Telecommunications (DoT).
BRK.A 500108 MTENY MTNL

3
An evening walk down Dalal Street | Last hour recovery helps D-Street cut losses, Nifty ends below 11,700

2018-08-30 moneycontrol
A good recovery in the last hour of trade helped D-Street cut big losses and end August series on a slightly better note. However, the Nifty managed to close below 11,700-mark. For the series, Nifty gained around 5 percent, while the Midcap index ended higher by 7 percent.
500108 532617 MTNL 532215 505200 500470 532187 AXISBANK MTENY BJJQY EICHERMOT 500034 ECQRY AXB INDUSINDBK IBN JETAIRWAYS AXBKY BRK.A AXBA ICICIBANK BAJFINANCE TTST TATASTEEL TATLY 532174

3
MTNL surges nearly 18% on buzz of Rs 30,600 cr financial aid by DoT to cut debt

2018-08-30 moneycontrol
Shares of government-owned telecom operator MTNL (Mahanagar Telephone Nigam) rose nearly 18 percent intraday on Thursday based on a report that informed about Rs 30,600-crore financial aid from Department of Telecommunications (DoT).
BRK.A 500108 MTENY MTNL

 
Mahanagar Telephone Nigam Limited - Updates

2018-08-27 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500108 MTENY MTNL

 
Mahanagar Telephone Nigam Limited - AGM/Book Closure

2018-08-27 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500108 MTENY MTNL

 
Mahanagar Telephone Nigam Limited - Shareholders meeting

2018-08-27 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500108 MTENY MTNL

 
Airtel, MTNL launch offers ahead of Reliance Jio GigaFiber launch

2018-07-09 livemint
New Delhi: As Reliance Jio GigaFiber is expected to offer fixed-line broadband services at aggressive prices, rivals are now gearing themselves up for cut-throat competition with Bharti Airtel reducing its prices for broadband services and even offering unlimited data for its customers. Mahanagar Telephone Nigam Limited (MTNL), on the other hand, is offering free 3G connection and data up to 10 GB with its broadband connection.
532454 500108 MTENY MTNL BHRQY BHARTIARTL

7
Huawei India shuts product assembling operations in Chennai

2018-06-16 moneycontrol
Owing to a huge drop in demand for its equipment and services due to rapid consolidation in the Indian telecom market, Huawei India had shut assembly of products at its Chennai plant. As India gets digitally advanced with more and more global corporations entering the economy, even big firms like Huawei, who were once leading telecom manufacturers, have started witnessing a significant drop in revenue.
532454 500108 IDEA MTENY ICLQY 532822 MTNL BHRQY BHARTIARTL

 
New telecom policy likely to be ready by July

2018-06-13 freepressjournal.in
New Delhi : The new telecom policy is expected to be cleared by the Cabinet by the end of next month, Communications Minister Manoj Sinha said on Tuesday.
500108 MTENY MTNL

 
Mahanagar Telephone Nigam Limited - Reply to Clarification- Financial results

2018-06-05 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500108 MTENY MTNL

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...